Impromidine
From Wikipedia, the free encyclopedia
 |
|
|
Impromidine
|
|
| Systematic (IUPAC) name | |
| N-[3-(imidazol-4-yl)-propyl]-N'-{2-[(5-methylimidazol-4-yl) methylthio]ethyl}-guanidine | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C14H23N7S |
| Mol. mass | 321.44 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
A highly potent and specific histamine H2 receptor agonist. It has been used diagnostically as a gastric secretion indicator.
[edit] references
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
